Vaccines, Blood & Biologics
-
TENIVAC
Proper Name: Tetanus and Diphtheria Toxoids Adsorbed For Adult Use
Tradename: TENIVAC
Manufacturer: Sanofi Pasteur, Ltd, License #1726
Date: June 5, 2008
New Indication: Use in adults 60 years of age and older for active immunization for the prevention of tetanus and diphtheria
June 5, 2008 Approval Letter
Date: November 3, 2003
Indication: Primary and booster immunization of persons 7 - 59 years of age against tetanus and diphtheria
November 3, 2003 Approval Letter
Clinical Review (PDF - 405 KB)
-
-